(Q43763736)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

title

Different forms of cell death induced by putative BCL2 inhibitors (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

1 reference

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Kathrin Weber

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

Martin Dyer

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

author name string

M Vogler

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

D Dinsdale

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

K Schulze-Osthoff

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

G M Cohen

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

publication date

24 April 2009

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

Cell Death & Differentiation

26 January 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

volume

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

page(s)

1030-1039

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

26 January 2020

issue

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1038/cdd.2009.48

26 January 2020

exact match

0 references

cites work

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Multiple cell death pathways as regulators of tumour initiation and progression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

The pathophysiology of mitochondrial cell death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Caspases: the executioners of apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

The Bcl-2 apoptotic switch in cancer development and therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Bcl-2 inhibitors: small molecules with a big impact on cancer therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Expanding circle of inhibition: small-molecule inhibitors of Bcl-2 as anticancer cell and antiangiogenic agents

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

An inhibitor of Bcl-2 family proteins induces regression of solid tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Studies leading to potent, dual inhibitors of Bcl-2 and Bcl-xL

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Chronic lymphocytic leukemia requires BCL2 to sequester prodeath BIM, explaining sensitivity to BCL2 antagonist ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Influence of Bcl-2 family members on the cellular response of small-cell lung cancer cell lines to ABT-737.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

The BH3 mimetic ABT-737 targets selective Bcl-2 proteins and efficiently induces apoptosis via Bak/Bax if Mcl-1 is neutralized.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Small molecule obatoclax (GX15-070) antagonizes MCL-1 and overcomes MCL-1-mediated resistance to apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Discovery, characterization, and structure-activity relationships studies of proapoptotic polyphenols targeting B-cell lymphocyte/leukemia-2 proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Rational design and real time, in-cell detection of the proapoptotic activity of a novel compound targeting Bcl-X(L).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Identification of chelerythrine as an inhibitor of BclXL function

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

The mitochondrial effects of small organic ligands of BCL-2: sensitization of BCL-2-overexpressing cells to apoptosis by a pyrimidine-2,4,6-trione derivative

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Bcl-2 antagonist apogossypol (NSC736630) displays single-agent activity in Bcl-2-transgenic mice and has superior efficacy with less toxicity compared with gossypol (NSC19048).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Chelerythrine is a potent and specific inhibitor of protein kinase C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Small-molecule inhibitors of Bcl-2 family proteins as therapeutic agents in cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Phase I study of obatoclax mesylate (GX15-070), a small molecule pan-Bcl-2 family antagonist, in patients with advanced chronic lymphocytic leukemia

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Loss of caspase-9 provides genetic evidence for the type I/II concept of CD95-mediated apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Loss of caspase-9 reveals its essential role for caspase-2 activation and mitochondrial membrane depolarization

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Apoptosis induced by histone deacetylase inhibitors in leukemic cells is mediated by Bim and Noxa.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

A novel paradigm for rapid ABT-737-induced apoptosis involving outer mitochondrial membrane rupture in primary leukemia and lymphoma cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Life in the balance: how BH3-only proteins induce apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Mechanisms of antileukemic activity of the novel Bcl-2 homology domain-3 mimetic GX15-070 (obatoclax).

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Chelerythrine induces apoptosis through a Bax/Bak-independent mitochondrial mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Bcl-2 family of proteins: life-or-death switch in mitochondria

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Gossypol, a BH3 mimetic, induces apoptosis in chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Gossypol induces apoptosis in human PC-3 prostate cancer cells by modulating caspase-dependent and caspase-independent cell death pathways

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

HA14-1, a small molecule inhibitor of Bcl-2, bypasses chemoresistance in leukaemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

The mitochondrial inner membrane protein mitofilin controls cristae morphology

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Intracellular adenosine triphosphate (ATP) concentration: a switch in the decision between apoptosis and necrosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Programmed anuclear cell death delimits platelet life span.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Gossypol reduction of tumor growth through ROS-dependent mitochondria pathway in human colorectal carcinoma cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Preclinical studies of the pan-Bcl inhibitor obatoclax (GX015-070) in multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Distinct caspase cascades are initiated in receptor-mediated and chemical-induced apoptosis.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

Bcl-2 inhibitors induce apoptosis in chronic lymphocytic leukemia cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FCDD.2009.48

inferred from DOI database lookup

7 January 2021

based on heuristic

Identifiers

DOI

10.1038/CDD.2009.48

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:19390557%20AND%20SRC:MED&resulttype=core&format=json

Dimensions Publication ID

26 January 2020

0 references

1 reference